Google
×
The Investor Relations website contains information about Medpace Holdings, Inc.'s business for stockholders, potential investors, and financial analysts.
Feb 15, 2024 · I would now like to introduce your host for today's conference call, Lauren Morris, Medpace's Director of Investor Relations. You may begin.
Investor Relations Intelligence. Featured Solutions. Nasdaq Boardvantage® · Board Evaluations · Nasdaq IR Insight® · Nasdaq Metrio · See All Solutions ->. About.
Feb 13, 2024 · (MEDP) Q4 2023 Earnings Call Transcript. Feb ... The slides are available in the Investor Relations section of our website at investor.medpace.com ...
14 hours ago · Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market ...
Rating (720,515)
Medpace Holdings (MEDP) stock investors activity – investors allocate an average of 3.59% to MEDP, based on 720515 active investor portfolios.
Medpace offers clinical pharmacology and laboratory services including central laboratory, bioanalytical, ECG core lab, and imaging core labs. Learn more.